Patents Assigned to Research, Incorporated
-
Patent number: 5534258Abstract: A vaccine is disclosed for the prophylaxis against pathogenic development of atherosclerotic plaque in a mammalian subject susceptible thereto which comprises:(a) 10 to 30% by weight of the compound ##STR1## (b) 10 to 30% by weight of the compound ##STR2## (c) 10 to 30% by weight of the compound ##STR3## (d) 10 to 30% by weight of the compound ##STR4## in combination with a pharmaceutically acceptable inert carrier.Type: GrantFiled: July 27, 1994Date of Patent: July 9, 1996Assignee: Bio-Virus Research IncorporatedInventors: Daniel B. Golubev, Alexander Chaihorsky
-
Patent number: 5523087Abstract: A pharmaceutical composition is disclosed for the treatment of diabetic male sexual dysfunction, which comprises:(a) 45 to 60 parts by weight of one or more phytoestrogen compounds calculated as a free aglycon form of isoflavone;(b) 0 to 400, preferably 200 to 300 parts by weight of phosphatidyl choline;(c) 10 to 50 parts by weight of beta-sitosterol;(d) 0 to 300, preferably 30 to 100 parts by weight of Damiana leaf dry extract;(e) 0 to 15, preferably 1 to 3 parts by weight of Vitamin A;(f) 0 to 250, preferably 20 to 100 parts by weight of Vitamin B1;(g) 0 to 300, preferably 50 to 150 parts by weight of Vitamin B6;(h) 0 to 100, preferably 10 to 70 parts by weight of Vitamin E;(i) 0 to 300, preferably 50 to 200 parts by weight of calcium contained in a biologically acceptable calcium salt;(j) 0 to 750, preferably 300 to 500 parts by weight of magnesium contained in a biologically acceptable magnesium salt; and(k) 0 to 100, preferably 10 to 90 parts by weight of zinc contained in a biologically acceptable zincType: GrantFiled: February 15, 1995Date of Patent: June 4, 1996Assignee: Bio-Virus Research IncorporatedInventor: Mark Shlyankevich
-
Patent number: 5502081Abstract: This invention describes a method for preparing water-insoluble biocompatible gels, films and sponges by reacting hyaluronic acid, or a salt thereof, with a carbodiimide in the absence of a nucleophile or a polyanionic polysaccharide. The water-insoluble gels, films and sponges of this invention may be used as surgical aids to prevent adhesions of body tissues and as drug delivery vehicles.Type: GrantFiled: August 18, 1994Date of Patent: March 26, 1996Assignees: Research Foundation of State University of New York, Anika Research, IncorporatedInventors: Jing-Wen Kuo, David A. Swann, Glenn D. Prestwich
-
Patent number: 5500540Abstract: A package and method for packaging optoelectronic or electronic components is provided in which multiple chip regions are packaged simultaneously prior to sectioning of the wafer into chips. The method and package allows micro-optic and other package elements to be integrated onto wafers on the same face as the optoelectronic or electronic devices without inhibiting the ability to make electrical contact to the devices. The package elements may be integrated to the wafer by material deposition, by spinning, or by physical mounting.Type: GrantFiled: April 15, 1994Date of Patent: March 19, 1996Assignee: Photonics Research IncorporatedInventors: Jack L. Jewell, William E. Quinn, Stan E. Swirhun, Robert P. Bryan
-
Patent number: 5482713Abstract: What is described is a recombinant poxvirus, such as vaccinia virus, fowlpox virus and canarypox virus, containing foreign DNA from herpesvirus. In one embodiment, the foreign DNA is expressed in a host by the production of a herpesvirus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two, particularly two or three, herpesvirus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, the barrier of maternal immunity in a newborn offspring can be overcome or avoided.Type: GrantFiled: September 21, 1993Date of Patent: January 9, 1996Assignee: Health Research IncorporatedInventor: Enzo Paoletti
-
Patent number: 5453364Abstract: What is described is a modified recombinant virus for expressing a gene product in a host. The modified recombinant virus has host range genes deleted therefrom so that the virus has restricted replication in the host. The modified recombinant virus also contains DNA which codes for and expresses the gene product in the host even with restricted replication of the virus in the host. The modified recombinant virus is used in a method for expressing a gene product in a host or in a cell cultured in vitro, and in a vaccine for inducing an immunological response in a host inoculated with the vaccine. What is also described is a selection system for the cloning and expression of open reading frames in poxviruses, particularly vaccinia virus. The selection system is based on a conditional lethal mutant (host range) of poxviruses.Type: GrantFiled: August 5, 1993Date of Patent: September 26, 1995Assignee: Health Research IncorporatedInventor: Enzo Paoletti
-
Patent number: 5446754Abstract: A phased array of semiconductor laser elements is provided in which the percentage of light which propagates into different diffractive orders is modified by an optical element. The diode laser includes a body of a semiconductor material having an active region therein which is adapted to generate radiation and emit the radiation form a surface of the body, and separate reflecting mirrors at opposite sides of the active region with at least one of the mirrors being partially transparent to the generated light to allow the light generated in the active region to be emitted therethrough. The optical element may take the form of a modification in the arrangement of the semiconductor laser elements, or an array of microprisms, or an external mirror to modify the percentage of light which propagates into different diffractive orders.Type: GrantFiled: November 5, 1993Date of Patent: August 29, 1995Assignee: Photonics Research IncorporatedInventors: Jack L. Jewell, Greg R. Olbright
-
Patent number: 5440101Abstract: A pass-through convection oven having a series of gas jet distributors and an exhaust system adjacent later distributors in the series to gather gas for the initial distributors in the series. A distributor in the series is formed of a pair of plenums in series in the gas flow path with a cumulative area of the passageway between them exceeding the cumulative area of the orifice from which the gas jets are formed in that distributor.Type: GrantFiled: April 19, 1993Date of Patent: August 8, 1995Assignee: Research, IncorporatedInventors: Norman R. Cox, Jean P. Menard, Wayne W. Baer, Bradley C. Anderson
-
Patent number: 5424331Abstract: A composition for the treatment or prevention of osteoporosis, is disclosed, which comprises:(a) 75 to 200 parts of one or more phytoestrogen compounds;(b) 0 to 100 parts of dried licorice root extract;(c) 300 to 600 parts of calcium contained in a biologically acceptable calcium salt;(d) 70 to 280 parts of magnesium contained in a biologically acceptable magnesium salt;(e) 4 to 25 parts of zinc contained in a biologically acceptable zinc salt;(f) 5 to 20 parts of beta-carotene;(g) 0.005 to 0.010 parts of Vitamin D as cholecalciferol; and(h) 6 to 12 parts of Vitamin E,in admixture with a biologically acceptable inert carrier. The new compositions are administered to a mammalian subject as either a pharmaceutical or as a dietary supplement.Type: GrantFiled: June 10, 1994Date of Patent: June 13, 1995Assignee: Bio-Virus Research IncorporatedInventor: Mark Shlyankevich
-
Patent number: 5420954Abstract: An optical interconnect is disclosed that couples multiple optical fibers to an array of optoelectronic devices. The interconnect includes a multiple optical fiber connector and an optoelectronic board. The multiple fiber connector can be mechanically attached to or detached from the board.Type: GrantFiled: May 24, 1993Date of Patent: May 30, 1995Assignee: Photonics Research IncorporatedInventors: Stanley E. Swirhun, Toshi K. Uchida
-
Patent number: 5412680Abstract: This invention discloses vertical cavity surface emitting lasers (VCSELs) formed to emit optical radiation that has a controlled direction of polarization. In one embodiment, a VCSEL has an active region that contains at least one strained semiconductor layer which has a preferred direction of electrical conductivity due to the strain. As a result, the optical radiation emitted from the VCSEL has a direction of polarization that is parallel to the preferred direction of conductivity. In another embodiment, a VCSEL has an elongated active region, and the direction of polarization of the radiation emitted from the VCSEL is parallel to a longitudinal axis of the active region. The invention also discloses a VCSEL array comprising vertical cavity surface emitting lasers having elongated active regions. By forming the elongated active regions parallel to each other, the array emits optical radiation having parallel polarization.Type: GrantFiled: March 18, 1994Date of Patent: May 2, 1995Assignee: Photonics Research IncorporatedInventors: Stanley E. Swirhun, Thomas J. O'Neill, Jr.
-
Patent number: 5394122Abstract: A digital-to analogue converter for producing an RF output signal proportional to a digital input word of N bits from an RF reference input, N being an integer greater or equal to 2. The converter comprises a plurality of power splitters, power combiners and a plurality of mixers or RF switches connected in a predetermined configuration.Type: GrantFiled: September 28, 1992Date of Patent: February 28, 1995Assignee: Duly Research IncorporatedInventors: Patrick H. Conway, David U. L. Yu
-
Patent number: 5381605Abstract: Method and apparatus for generating and delivering a gas that contains vapor produced by subliming a solid for use in chemical vapor deposition processes such as Metal Organic Molecular Beam Epitaxy (MOMBE) and Organometallic Vapor Phase Epitaxy (OMVPE). The method includes generating a gas saturated with the vapor and subsequently diluting the gas with an inert gas to obtain an uniform non-saturated gas. The apparatus includes a vessel for containing a sublimable solid, a heater for maintaining the vessel at a desired temperature, tubes and valves for introducing a gas into the vessel and for discharging a gas that is saturated with the vapor of the solid from the vessel, and a tube and a valve for diluting a gas discharged from the vessel.Type: GrantFiled: January 8, 1993Date of Patent: January 17, 1995Assignee: Photonics Research IncorporatedInventor: Terry Krafft
-
Patent number: 5338683Abstract: What is described is a recombinant poxvirus, such as vaccinia virus, fowlpox virus and canarypox virus, containing foreign DNA from herpesvirus. In one embodiment, the foreign DNA is expressed in a host by the production of a herpesvirus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two, particularly two or three, herpesvirus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, the barrier of maternal immunity in a newborn offspring can be overcome or avoided.Type: GrantFiled: April 4, 1990Date of Patent: August 16, 1994Assignee: Health Research IncorporatedInventor: Enzo Paoletti
-
Patent number: 5331654Abstract: A vertical-cavity, surface-emitting semiconductor diode laser having a monolithic and planar surface and having lateral anisotropy in order to control the polarization of the emitted beam of light. The diode laser includes a body of a semiconductor material having an active region therein which is adapted to generate radiation and emit the radiation from a surface of the body, and a separate reflecting mirror at opposite sides of the active region with at least one of the mirrors being partially transparent to the generated light to allow the light generated in the active region to be emitted therethrough. The anisotropy may be provided by utilizing anisotropy in the atomic or molecular structure of the materials forming the laser, or by anisotropic patterning or deliberate offset alignment in processing of the laser or through anisotropic structures in the laser cavity to control the polarization of the emitted beam.Type: GrantFiled: March 5, 1993Date of Patent: July 19, 1994Assignee: Photonics Research IncorporatedInventors: Jack L. Jewell, Greg R. Olbright
-
Patent number: 5319496Abstract: The present invention is directed to an optical system which includes an image region having at least one light source which directs a beam of light along an optical axis and an object region which is adapted to receive the light from the light source. An optical delivery system is between the image region and object region. The optical delivery system receives the light from the image region and directs it to the object region. The optical delivery system is formed of a plurality of optical elements, such as lenses and volume holograms. The optical delivery system is designed to either receive a plurality of beams of light from a plurality of sources or different modes of a single light source and form a single spot of light in the image region having the combined power of all of the beams of light or modes of a single beam. The optical delivery system can also condense or expand the spacing between the beams of light from a plurality of light sources.Type: GrantFiled: November 18, 1992Date of Patent: June 7, 1994Assignee: Photonics Research IncorporatedInventors: Jack L. Jewell, Greg R. Olbright
-
Patent number: 5295147Abstract: A vertical-cavity, surface-emitting semiconductor laser having a substrate, an active layer of a semiconductor material which is adapted to generate light on a surface of the substrate, a pair of mirrors at opposite sides of the active layer and means for expanding the diameter of the output beam. Such means include a spacer layer of an optically passive material between the active layer and at least one of the mirrors, and mirror layers of reduced difference in index of refraction, interface layers having intermediate indices of refraction placed between mirror layers, in either case expanding the effective optical cavity length to at least 100 times the thickness of the active material in the active layer. Another means is anti-waveguiding which directly expands the diameter of the beam. The expanded cavity provides an output beam of larger diameter while maintaining stable single mode emission. The spacer layer may be a separate layer or region over the substrate or at least a portion of the substrate.Type: GrantFiled: December 22, 1992Date of Patent: March 15, 1994Assignee: Photonics Research IncorporatedInventors: Jack L. Jewell, Greg R. Olbright
-
Patent number: 5225336Abstract: What is described is a modified recombinant virus for expressing a gene product in a host. The modified recombinant virus has host range genes deleted therefrom so that the virus has restricted replication in the host. The modified recombinant virus also contains DNA which codes for and expresses the gene product in the host even with restricted replication of the virus in the host. The modified recombinant virus is used in a method for expressing a gene product in a host or in a cell cultured in vitro, and in a vaccine for inducing an immunological response in a host inoculated with the vaccine. What is also described is a selection system for the cloning and expression of open reading frames in poxviruses, particularly vaccinia virus. The selection system is based on a conThis invention was made with Government support under contract DAMD17-85-C-5232 awarded by the Department of the Army. The Government has certain rights in this invention.Type: GrantFiled: June 23, 1992Date of Patent: July 6, 1993Assignee: Health Research IncorporatedInventor: Enzo Paoletti
-
Patent number: 5204243Abstract: What is described is a modified recombinant poxvirus, such as vaccinia virus, fowlpox virus and canarypox virus, having an internal core containing DNA from a non-pox source in a nonessential region of the poxvirus genome. The recombinant poxvirus is modified by disassociating the internal core from outer membranes of the poxvirus. The DNA codes for and expresses a gene product in a cell cultured in vitro and in a host in vivo without productive replication of the virus in the cell or in the host. What is also described is a vaccine containing the modified recombinant poxvirus for inducing an immunological response in a host inoculated with the vaccine.Type: GrantFiled: February 14, 1990Date of Patent: April 20, 1993Assignee: Health Research IncorporatedInventor: Enzo Paoletti
-
Patent number: D361562Type: GrantFiled: October 11, 1994Date of Patent: August 22, 1995Assignee: Renaissance Research IncorporatedInventor: Michael A. Beltz